 |
| Lisa Davidson |
Lisa Davidson exits her role as managing director at Havas Health & You to become executive VP and lead for client services and global business development at Bliss Bio Health, the Next Practices Group’s life sciences marketing communications firm. She will be based in the firm’s New York office.
Before coming on board at Havas in 2020, Davidson held leadership positions at BCW, Burson-Marsteller and Porter Novelli.
She brings expertise in pre-clinical and clinical educational campaigns, advocacy development, product marketing, medical devices, reputation, and issues management.
Davidson’s hiring follows the January appointment of Gloria Vanderham to serve as CEO of both Next Practices Group Health and Bliss Bio Health.
“Our team and clients will benefit from Lisa’s deep experience in working ‘from atom to access’ with both integrated agency teams and healthcare companies in a wide range of disease areas,” said Vanderham. “Lisa will help us redefine the life sciences and healthcare marketing communications landscape.”
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
